Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$14.41 - $33.99 $122,485 - $288,915
8,500 Added 34.14%
33,400 $1.04 Million
Q2 2024

Aug 15, 2024

SELL
$7.56 - $16.15 $120,960 - $258,399
-16,000 Reduced 39.12%
24,900 $386,000
Q1 2024

May 07, 2024

BUY
$7.96 - $12.37 $240,392 - $373,574
30,200 Added 282.24%
40,900 $433,000
Q4 2023

Feb 14, 2024

BUY
$4.9 - $12.86 $52,430 - $137,602
10,700 New
10,700 $128,000
Q2 2023

Aug 11, 2023

SELL
$7.61 - $9.46 $35,006 - $43,516
-4,600 Reduced 17.76%
21,300 $181,000
Q1 2023

May 16, 2023

SELL
$8.83 - $17.61 $13,245 - $26,415
-1,500 Reduced 5.47%
25,900 $236,000
Q4 2022

Feb 14, 2023

BUY
$10.88 - $20.05 $108,800 - $200,500
10,000 Added 57.47%
27,400 $312,000
Q3 2022

Nov 14, 2022

SELL
$16.06 - $26.39 $326,018 - $535,717
-20,300 Reduced 53.85%
17,400 $296,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.13B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.